Molecular signatures provide new targets for treatments
Posted on 22/01/21
Scientists have discovered that the common autoimmune diseases type 1 diabetes, lupus multiple sclerosis and rheumatoid arthritis share common molecular signatures that could prove a useful target for new treatments.